Gross Profit Summary of PharmaEngine, Inc.

PharmaEngine, Inc.'s latest annual gross profit in 2023 was 718.97 Million TWD , up 18.9% from previous year.
PharmaEngine, Inc.'s latest quarterly gross profit in 2024 Q2 was 250.34 Million TWD , up 63.17% from previous quarter.
PharmaEngine, Inc. reported a annual gross profit of 604.68 Million TWD in annual gross profit 2022, down -2.12% from previous year.
PharmaEngine, Inc. reported a annual gross profit of 617.76 Million TWD in annual gross profit 2021, down -39.36% from previous year.
PharmaEngine, Inc. reported a quarterly gross profit of 153.42 Million TWD for 2024 Q1, down -13.07% from previous quarter.
PharmaEngine, Inc. reported a quarterly gross profit of 234.33 Million TWD for 2023 Q3, up 52.72% from previous quarter.

Annual Gross Profit Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Gross Profit of PharmaEngine, Inc. (2023 - 2009)

Year	Gross Profit	Gross Profit Growth
2023	718.97 Million TWD	18.9%
2022	604.68 Million TWD	-2.12%
2021	617.76 Million TWD	-39.36%
2020	1.01 Billion TWD	260.96%
2019	282.24 Million TWD	0.6%
2018	280.54 Million TWD	-67.03%
2017	850.84 Million TWD	-24.89%
2016	1.13 Billion TWD	126.37%
2015	500.4 Million TWD	125.43%
2014	221.98 Million TWD	1192.16%
2013	17.17 Million TWD	-89.99%
2012	171.69 Million TWD	-44.92%
2011	311.72 Million TWD	0.0%
2010	- TWD	0.0%
2009	- TWD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	250.34 Million TWD	63.17%
2024 Q1	153.42 Million TWD	-13.07%
2023 Q3	234.33 Million TWD	52.72%
2023 Q4	176.48 Million TWD	-24.69%
2023 FY	718.97 Million TWD	18.9%
2023 Q1	154.7 Million TWD	5.82%
2023 Q2	153.44 Million TWD	-0.82%
2022 Q1	162.49 Million TWD	-17.18%
2022 Q2	154.58 Million TWD	-4.86%
2022 Q3	141.41 Million TWD	-8.52%
2022 Q4	146.19 Million TWD	3.38%
2022 FY	604.68 Million TWD	-2.12%
2021 Q1	106.45 Million TWD	-86.3%
2021 Q2	148.21 Million TWD	39.22%
2021 Q3	166.89 Million TWD	12.6%
2021 Q4	196.2 Million TWD	17.56%
2021 FY	617.76 Million TWD	-39.36%
2020 Q3	85.89 Million TWD	6.18%
2020 Q2	80.9 Million TWD	8.2%
2020 FY	1.01 Billion TWD	260.96%
2020 Q1	74.77 Million TWD	10.65%
2020 Q4	777.21 Million TWD	804.83%
2019 Q3	73.3 Million TWD	3.17%
2019 FY	282.24 Million TWD	0.6%
2019 Q4	67.57 Million TWD	-7.81%
2019 Q2	71.05 Million TWD	1.05%
2019 Q1	70.31 Million TWD	-2.15%
2018 Q2	42.66 Million TWD	39.59%
2018 Q3	135.46 Million TWD	217.5%
2018 FY	280.54 Million TWD	-67.03%
2018 Q4	71.85 Million TWD	-46.96%
2018 Q1	30.56 Million TWD	-96.1%
2017 Q1	10.49 Million TWD	-98.7%
2017 Q3	28.3 Million TWD	0.41%
2017 Q2	28.18 Million TWD	168.52%
2017 Q4	783.85 Million TWD	2669.4%
2017 FY	850.84 Million TWD	-24.89%
2016 FY	1.13 Billion TWD	126.37%
2016 Q4	805.72 Million TWD	31361.5%
2016 Q3	2.56 Million TWD	-99.21%
2016 Q2	324.29 Million TWD	162859.8%
2016 Q1	199 Thousand TWD	-14.22%
2015 FY	500.4 Million TWD	125.43%
2015 Q4	232 Thousand TWD	-89.49%
2015 Q3	2.2 Million TWD	-99.56%
2015 Q2	495.95 Million TWD	24574.58%
2015 Q1	2.01 Million TWD	-35.91%
2014 Q3	213.7 Million TWD	9500.49%
2014 Q2	2.22 Million TWD	-23.56%
2014 Q1	2.91 Million TWD	-5.97%
2014 FY	221.98 Million TWD	1192.16%
2014 Q4	3.13 Million TWD	-98.53%
2013 Q3	4.65 Million TWD	-7.41%
2013 Q1	4.39 Million TWD	-15.91%
2013 Q2	5.03 Million TWD	14.6%
2013 Q4	3.09 Million TWD	-33.53%
2013 FY	17.17 Million TWD	-89.99%
2012 Q3	5.14 Million TWD	-16.83%
2012 Q4	5.22 Million TWD	1.44%
2012 Q2	6.19 Million TWD	-96.01%
2012 FY	171.69 Million TWD	-44.92%
2012 Q1	155.13 Million TWD	1015.15%
2011 Q2	285.7 Million TWD	0.0%
2011 FY	311.72 Million TWD	0.0%
2011 Q4	13.91 Million TWD	14.82%
2011 Q1	- TWD	0.0%
2011 Q3	12.11 Million TWD	-95.76%
2010 FY	- TWD	0.0%
2009 FY	- TWD	0.0%

Peer Gross Profit Comparison of PharmaEngine, Inc.

Name	Gross Profit	Gross Profit Difference
SYN-TECH Chem. & Pharm. Co., Ltd.	402.54 Million TWD	-78.607%
Level Biotechnology Inc.	219.54 Million TWD	-227.483%
TaiMed Biologics Inc.	225.23 Million TWD	-219.213%
GlycoNex Incorporation	995 Thousand TWD	-72158.492%
GeneReach Biotechnology Corp.	27.58 Million TWD	-2506.482%
OBI Pharma, Inc.	-73.49 Million TWD	1078.233%
Taiwan Advance Bio-Pharmaceutical Inc.	198.45 Million TWD	-262.285%
Genomics BioSci & Tech. Co.,Ltd.	119.91 Million TWD	-499.593%
Visgeneer Inc.	67.48 Million TWD	-965.428%
Neith Corporation	18.01 Million TWD	-3890.077%
Lumosa Therapeutics Co., Ltd.	41.48 Million TWD	-1633.256%
Medigen Vaccine Biologics Corporation	230.22 Million TWD	-212.295%
TaiwanJ Pharmaceuticals Co., Ltd.	22.74 Million TWD	-3061.428%
Enimmune corporation	-23.37 Million TWD	3176.079%
TaiRx, Inc.	2.43 Million TWD	-29378.147%
CHO Pharma, Inc.	-28.27 Million TWD	2642.424%
BioLASCO Taiwan Co., Ltd.	104.35 Million TWD	-588.994%
Sunny Pharmtech Inc.	285.52 Million TWD	-151.806%
Ever Supreme Bio Technology Co., Ltd	484.75 Million TWD	-48.317%
Feng Chi Biotech Corp.	80.72 Million TWD	-790.688%
Lukas Biomedical Inc.	133.89 Million TWD	-436.987%
RBC Bioscience Corporation	72.89 Million TWD	-886.312%
NaviFUS Corp.	11.82 Million TWD	-5979.073%
BRIM Biotechnology, Inc.	90 Thousand TWD	-798757.778%
Shine-On BioMedical Co.,Ltd.	6.66 Million TWD	-10684.041%
Great Novel Therapeutics Biotech & Medicals	2.61 Million TWD	-27394.149%
Sagittarius Life Science Corp	71.47 Million TWD	-905.879%
Bio Preventive Medicine Corp.	1.08 Million TWD	-66287.073%
Advagene Biopharma Co., Ltd.	-12 Million TWD	6090.435%
BioGend Therapeutics Co., Ltd.	89.61 Million TWD	-702.263%
G&E Herbal Biotechnology Co., Ltd.	144.58 Million TWD	-397.259%
Andros Pharmaceuticals Co.,Ltd	313 Thousand TWD	-229603.514%
Lin BioScience, Inc.	-17.92 Million TWD	4110.554%
Anti-Microbial Savior BioteQ Co., Ltd	329 Thousand TWD	-218432.523%
AP Biosciences Inc	32.25 Million TWD	-2129.163%
Sunmax Biotechnology Co., Ltd.	1.4 Billion TWD	48.824%
Syngen Biotech Co.,Ltd.	643.91 Million TWD	-11.656%
EirGenix Inc.	236.74 Million TWD	-203.696%
Pharmosa Biopharm Inc.	314.5 Million TWD	-128.608%
Mycenax Biotech Inc.	-375.19 Million TWD	291.628%
SynCore Biotechnology Co.,Ltd	521 Thousand TWD	-137898.464%
Eusol Biotech Co.,Ltd.	-4.02 Million TWD	17944.924%
NeoCore Technology Co., Ltd.	-9.08 Million TWD	8013.836%
VBI	16.42 Million TWD	-4277.836%
BiOptic Inc.	152.74 Million TWD	-370.701%
Gwo Xi Stem Cell Applied Technology Co. , Ltd	96.77 Million TWD	-642.939%
Sinew Pharma Inc.	-28.98 Million TWD	2580.497%
Greenyn Biotechnology Co., Ltd	392.45 Million TWD	-83.198%
Medigen Biotechnology Corp.	617.32 Million TWD	-16.465%
3D Global Biotech Inc.	5.27 Million TWD	-13532.385%
Intech Biopharm Corporation	-163.99 Million TWD	538.411%
Oneness Biotech Co., Ltd.	32.56 Million TWD	-2108.009%
TWi Biotechnology, Inc.	-9.73 Million TWD	7482.401%
TCI GENE Inc.	174.61 Million TWD	-311.742%
MegaPro Biomedical Co., Ltd	-16.6 Million TWD	4430.896%
Senhwa Biosciences, Inc.	-10.17 Million TWD	7167.453%
Taiwan Bio Therapeutics Co., Ltd	76.35 Million TWD	-841.568%
NatureWise Biotech & Medicals Corporation	76.96 Million TWD	-834.179%
Savior Lifetec Corporation	220.94 Million TWD	-225.402%
TaiGen Biopharmaceuticals Holdings Limited	111.68 Million TWD	-543.744%
Meribank Biotech Co., Ltd	138.87 Million TWD	-417.73%
Acepodia, Inc.	16.59 Million TWD	-4232.984%
Caliway Biopharmaceuticals Co., Ltd.	27.46 Million TWD	-2517.394%

Global Stocks Search

PharmaEngine, Inc. (4162.TWO)

Gross Profit Summary of PharmaEngine, Inc.

Annual Gross Profit Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Gross Profit of PharmaEngine, Inc. (2023 - 2009)

Peer Gross Profit Comparison of PharmaEngine, Inc.